Cardiovascular Disease

Showing NaN - NaN of 32

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cardiovascular Disease, Hypertension, Diabetes Trial in Boston, Philadelphia, Charleston (Unmet Need Screening, Unmet Need

Recruiting
  • Cardiovascular Disease
  • +3 more
  • Unmet Need Screening
  • +2 more
  • Boston, Massachusetts
  • +2 more
Aug 12, 2022

Heart Failure, Anemia, Cardiovascular Disease Trial in Worldwide (Darbepoetin alfa, Placebo)

Completed
  • Heart Failure
  • +4 more
  • Darbepoetin alfa
  • Placebo
  • Birmingham, Alabama
  • +753 more
Oct 31, 2021

Diabetes, Hyperlipidemia, Hypertension Trial in United States (CVRS Intervention)

Completed
  • Diabetes
  • +3 more
  • CVRS Intervention
  • Gainesville, Florida
  • +17 more
Jul 22, 2021

Elevated Lipoprotein(a), Cardiovascular Disease Trial in Worldwide (ISIS 681257, Placebo)

Completed
  • Elevated Lipoprotein(a)
  • Cardiovascular Disease
  • ISIS 681257
  • Placebo
  • Cottonwood, Arizona
  • +31 more
Oct 26, 2020

Cardiovascular Disease Trial in Canada, Puerto Rico, United States (Methotrexate, Placebo)

Completed
  • Cardiovascular Disease
  • Birmingham, Alabama
  • +469 more
Jul 23, 2020

Psoriasis, Cardiovascular Disease Trial in Philadelphia (Ustekinumab, Placebo)

Completed
  • Psoriasis
  • Cardiovascular Disease
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Aug 14, 2019

Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)

Completed
  • Cardiovascular Disease
  • +4 more
  • Lorcaserin hydrochloride
  • Placebo
  • Alexander City, Alabama
  • +498 more
Jun 27, 2019

Cardiovascular Disease Trial in Worldwide (bococizumab (PF-04950615), Placebo)

Terminated
  • Cardiovascular Disease
  • bococizumab (PF-04950615)
  • Placebo
  • Athens, Alabama
  • +1595 more
Apr 18, 2019

Diabetes, Cardiovascular Disease Trial in Philadelphia (Process Incentive, Outcome Incentive)

Completed
  • Diabetes
  • Cardiovascular Disease
  • Process Incentive
  • Outcome Incentive
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Feb 25, 2019

HIV, Cardiovascular Disease, Diabetes Trial in Philadelphia (Health Promotion Intervention, Health Awareness Control

Completed
  • HIV
  • +4 more
  • Health Promotion Intervention
  • Health Awareness Control Intervention
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Feb 4, 2019

Cardiovascular Disease, Hypertension Trial in Philadelphia (Health System: HTN Intervention)

Completed
  • Cardiovascular Disease
  • Hypertension
  • Health System: HTN Intervention
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 22, 2019

Diabetes, Cardiovascular Disease Trial in Philadelphia (Twitter Diabetes Intervention)

Completed
  • Diabetes
  • Cardiovascular Disease
  • Twitter Diabetes Intervention
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jul 31, 2018

Cardiovascular Disease Trial in Worldwide (bococizumab (PF-04950615), Placebo)

Terminated
  • Cardiovascular Disease
  • bococizumab (PF-04950615)
  • Placebo
  • Athens, Alabama
  • +1745 more
Jun 14, 2018

Cardiovascular Disease Trial in Mexico, United States (Febuxostat, Allopurinol)

Completed
  • Cardiovascular Disease
  • Decatur, Georgia
  • +202 more
Jun 12, 2018

Psoriasis, Cardiovascular Disease Trial in United States (Adalimumab (Humira), Placebo Injection, NB-UVB phototherapy)

Completed
  • Psoriasis
  • Cardiovascular Disease
  • Adalimumab (Humira)
  • +2 more
  • Sacramento, California
  • +8 more
Apr 23, 2018

Psoriasis, Cardiovascular Disease Trial in United States (Adalimumab)

Completed
  • Psoriasis
  • Cardiovascular Disease
  • Sacramento, California
  • +8 more
Apr 23, 2018

Cardiovascular Disease Trial in Boston, Danville, Philadelphia (Behavioral Economic Intervention)

Completed
  • Cardiovascular Disease
  • Behavioral Economic Intervention
  • Boston, Massachusetts
  • +2 more
Oct 31, 2017

Chronic Kidney Disease, Cardiovascular Disease, Death Trial in Brazil, Canada, United States (High Dose Multivitamin, Low Dose

Completed
  • Chronic Kidney Disease
  • +2 more
  • High Dose Multivitamin
  • Low Dose Multivitamin
  • Birmingham, Alabama
  • +29 more
Sep 17, 2017

Cardiovascular Disease Trial in Canada, China, United States (Education)

Completed
  • Cardiovascular Disease
  • Education
  • Long Beach, California
  • +15 more
Aug 28, 2017

Cardiovascular Disease Trial in Worldwide (EVARRESTâ„¢ Fibrin Sealant Patch, Topical hemostat)

Completed
  • Cardiovascular Disease
  • EVARRESTâ„¢ Fibrin Sealant Patch
  • Topical hemostat
  • Atlanta, Georgia
  • +23 more
Aug 14, 2017

Obesity, MDD, Dysthymic Disorder Trial in Philadelphia (Behavior Modification for Weight Loss, Alternative Approach to Weight

Completed
  • Obesity
  • +3 more
  • Behavior Modification for Weight Loss
  • +3 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania: Center for Weight and Eating Disorde
Aug 18, 2016

Cardiovascular Disease Trial in Philadelphia (Fenofibrate (Tricor) tablets, Placebo, Lovaza)

Completed
  • Cardiovascular Disease
  • Fenofibrate (Tricor) tablets
  • +2 more
  • Philadelphia, Pennsylvania
    Clinical and Translational Research Center (CTRC); Hospital of t
Jan 21, 2016

Type 2 Diabetes, Cardiovascular Disease Trial in Worldwide (TAK-875, TAK-875 Placebo)

Terminated
  • Type 2 Diabetes
  • Cardiovascular Disease
  • Birmingham, Alabama
  • +587 more
Oct 15, 2015

Hypertriglyceridemia, Cardiovascular Disease Trial in United States (Olive oil, 4g, omega-3-carboxylic acids, 2g,

Completed
  • Hypertriglyceridemia
  • Cardiovascular Disease
  • Olive oil, 4g
  • +2 more
  • Muscle Shoals, Alabama
  • +89 more
Nov 27, 2014

Physician Utilization of Shock Reduction Programming

Completed
  • Cardiovascular Disease
  • Therapy Programming Report (TPR)
  • Anniston, Alabama
  • +103 more
Jul 1, 2014